Subclinical Left Ventricular Dysfunction Prevention in Breast Cancer Patients After FAC Chemotherapy: A Carvedilol Trial. IJIHS 2024, 12 (1), 55-64. https://doi.org/10.15850/ijihs.v12.n1.3570.